Eventide Asset Management - Q3 2023 holdings

$5.56 Billion is the total value of Eventide Asset Management's 155 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 27.3% .

 Value Shares↓ Weighting
ODFL SellOLD DOMINION FREIGHT LINE IN$181,618,064
+10.4%
443,902
-0.2%
3.26%
+17.4%
TT BuyTRANE TECHNOLOGIES PLC$160,424,704
+6.3%
790,620
+0.2%
2.88%
+13.0%
ARGX SellARGENX SEsponsored adr$157,987,759
+23.2%
321,355
-2.3%
2.84%
+31.0%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$156,749,622
-19.2%
7,814,039
+13.6%
2.82%
-14.1%
FLYW BuyFLYWIRE CORPORATION$129,832,737
+2.8%
4,071,268
+0.1%
2.33%
+9.3%
EXAS BuyEXACT SCIENCES CORP$127,438,371
-27.3%
1,868,050
+0.0%
2.29%
-22.7%
MIRM BuyMIRUM PHARMACEUTICALS INC$125,091,097
+39.8%
3,958,579
+14.4%
2.25%
+48.7%
PANW SellPALO ALTO NETWORKS INC$124,939,640
-31.2%
532,928
-25.0%
2.25%
-26.8%
MTD SellMETTLER TOLEDO INTERNATIONAL$120,101,491
-23.6%
108,388
-9.6%
2.16%
-18.8%
ROP BuyROPER TECHNOLOGIES INC$114,826,178
+0.8%
237,107
+0.1%
2.06%
+7.3%
WCN SellWASTE CONNECTIONS INC$108,041,933
-6.6%
804,482
-0.6%
1.94%
-0.7%
GH SellGUARDANT HEALTH INC$106,393,669
-25.9%
3,589,530
-10.5%
1.91%
-21.2%
DLO SellDLOCAL LTD$104,896,016
+50.8%
5,471,884
-4.0%
1.88%
+60.3%
POOL BuyPOOL CORP$102,235,954
-3.2%
287,099
+1.9%
1.84%
+3.0%
IDXX SellIDEXX LABS INC$97,976,465
-18.9%
224,064
-6.9%
1.76%
-13.8%
GLBE SellGLOBAL E ONLINE LTD$97,396,660
-3.4%
2,450,847
-0.5%
1.75%
+2.8%
LOW SellLOWES COS INC$92,790,168
-8.3%
446,450
-0.5%
1.67%
-2.5%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$83,588,568
+14.4%
499,394
+0.4%
1.50%
+21.7%
DHI BuyD R HORTON INC$80,730,819
-3.6%
751,194
+9.1%
1.45%
+2.5%
HZNP BuyHORIZON THERAPEUTICS PUB L$79,795,095
+12.5%
689,732
+0.0%
1.43%
+19.6%
TTD BuyTHE TRADE DESK INC$79,137,972
+1.8%
1,012,642
+0.6%
1.42%
+8.2%
APTV SellAPTIV PLC$77,361,700
-6.3%
784,681
-2.9%
1.39%
-0.4%
XMTR BuyXOMETRY INC$74,021,135
+9.5%
4,359,313
+36.6%
1.33%
+16.5%
LAD BuyLITHIA MTRS INC$73,098,310
-1.6%
247,514
+1.3%
1.31%
+4.6%
LRCX SellLAM RESEARCH CORP$72,655,805
-3.7%
115,921
-1.2%
1.31%
+2.4%
EVH BuyEVOLENT HEALTH INCcl a$71,858,336
-10.1%
2,638,940
+0.0%
1.29%
-4.4%
SWAV BuySHOCKWAVE MED INC$70,823,255
+2.3%
355,717
+46.7%
1.27%
+8.8%
COUR BuyCOURSERA INC$69,039,178
+55.9%
3,693,910
+8.6%
1.24%
+65.7%
HUBS SellHUBSPOT INC$68,995,803
-27.3%
140,093
-21.5%
1.24%
-22.7%
DDOG BuyDATADOG INC$66,580,687
+36.5%
730,933
+47.4%
1.20%
+45.3%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$58,810,315
+4.0%
2,631,334
+0.0%
1.06%
+10.6%
KRTX SellKARUNA THERAPEUTICS INC$57,463,546
-22.1%
339,840
-0.0%
1.03%
-17.1%
BuyTOAST INCcl a$54,805,366
+51.4%
2,926,074
+82.4%
0.98%
+60.9%
TREX BuyTREX CO INC$54,390,324
-6.0%
882,530
+0.0%
0.98%0.0%
ASND BuyASCENDIS PHARMA A/Ssponsored adr$53,884,014
+4.9%
575,438
+0.0%
0.97%
+11.5%
DV BuyDOUBLEVERIFY HLDGS INC$53,678,758
-26.8%
1,920,528
+1.9%
0.96%
-22.2%
TMDX BuyTRANSMEDICS GROUP INC$50,663,241
+794.3%
925,356
+1271.7%
0.91%
+849.0%
LNG BuyCHENIERE ENERGY INC$49,989,641
+8.9%
301,215
+0.0%
0.90%
+15.7%
SPT SellSPROUT SOCIAL INC$49,327,379
+6.6%
988,921
-1.4%
0.89%
+13.4%
TRGP BuyTARGA RES CORP$49,259,341
+65.2%
574,654
+46.7%
0.88%
+75.6%
ENTG SellENTEGRIS INC$47,671,533
-15.3%
507,630
-0.0%
0.86%
-9.9%
MPWR BuyMONOLITHIC PWR SYS INC$45,425,688
-13.6%
98,324
+1.0%
0.82%
-8.2%
FIVN BuyFIVE9 INC$44,627,608
-21.9%
694,053
+0.1%
0.80%
-17.0%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$44,032,000
-5.8%
1,600,000
+16.1%
0.79%
+0.1%
SHLS SellSHOALS TECHNOLOGIES GROUP INcl a$42,569,512
-32.2%
2,332,576
-5.0%
0.76%
-27.9%
NVT SellNVENT ELECTRIC PLC$41,751,722
+0.7%
787,917
-1.8%
0.75%
+7.0%
ASML BuyASML HOLDING N V$41,142,036
-18.1%
69,891
+0.9%
0.74%
-13.0%
LSCC BuyLATTICE SEMICONDUCTOR CORP$36,778,298
-10.5%
428,003
+0.0%
0.66%
-4.9%
BuyMARINUS PHARMACEUTICALS INC$36,466,476
+5.8%
4,529,997
+42.8%
0.66%
+12.5%
SNPS BuySYNOPSYS INC$36,260,925
+6.5%
79,005
+1.0%
0.65%
+13.2%
CDW SellCDW CORP$34,038,930
+9.2%
168,710
-0.6%
0.61%
+16.1%
NARI  INARI MED INC$33,544,576
+12.5%
512,9140.0%0.60%
+19.6%
MNDY NewMONDAY COM LTD$32,419,899203,617
+100.0%
0.58%
KLAC BuyKLA CORP$30,746,273
+4.4%
67,035
+10.4%
0.55%
+11.0%
CRNX BuyCRINETICS PHARMACEUTICALS IN$30,298,577
+286.7%
1,018,782
+134.3%
0.54%
+312.9%
HASI SellHANNON ARMSTRONG SUST INFR C$29,219,833
-15.2%
1,378,294
-0.0%
0.52%
-9.9%
ORLY BuyOREILLY AUTOMOTIVE INC$27,931,086
-4.0%
30,732
+1.0%
0.50%
+2.2%
SGEN BuySEAGEN INC$27,789,529
+10.2%
130,990
+0.0%
0.50%
+17.1%
RPRX SellROYALTY PHARMA PLC$27,252,522
-14.7%
1,004,146
-3.4%
0.49%
-9.3%
BuyAURA BIOSCIENCES INC$27,133,398
-25.2%
3,024,905
+3.0%
0.49%
-20.4%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$26,870,640
-26.3%
1,236,0000.0%0.48%
-21.6%
WMB SellWILLIAMS COS INC$26,487,651
-9.6%
786,217
-12.5%
0.48%
-3.8%
FANG BuyDIAMONDBACK ENERGY INC$26,283,601
+75.9%
169,703
+49.2%
0.47%
+86.6%
MRTX  MIRATI THERAPEUTICS INC$26,136,000
+20.6%
600,0000.0%0.47%
+28.4%
AKRO BuyAKERO THERAPEUTICS INC$25,991,848
+46.8%
513,876
+35.5%
0.47%
+56.2%
INSP BuyINSPIRE MED SYS INC$24,822,860
-29.3%
125,090
+15.6%
0.45%
-24.9%
AJG BuyGALLAGHER ARTHUR J & CO$24,743,853
+15.5%
108,559
+11.2%
0.44%
+22.9%
AXSM NewAXSOME THERAPEUTICS INC$24,231,702346,712
+100.0%
0.44%
FERG NewFERGUSON PLC NEW$24,012,949146,002
+100.0%
0.43%
SHW BuySHERWIN WILLIAMS CO$23,749,491
-2.9%
93,117
+1.1%
0.43%
+3.4%
PRVA  PRIVIA HEALTH GROUP INC$23,000,000
-11.9%
1,000,0000.0%0.41%
-6.3%
IRTC  IRHYTHM TECHNOLOGIES INC$22,540,865
-9.6%
239,1350.0%0.40%
-4.0%
ISRG BuyINTUITIVE SURGICAL INC$22,330,664
-13.0%
76,399
+1.8%
0.40%
-7.6%
STE SellSTERIS PLC$22,265,645
-11.4%
101,475
-9.1%
0.40%
-5.9%
BPMC  BLUEPRINT MEDICINES CORP$22,021,470
-20.5%
438,5000.0%0.40%
-15.4%
PRTA  PROTHENA CORP PLC$21,478,729
-29.3%
445,1550.0%0.39%
-24.9%
PNR BuyPENTAIR PLC$21,383,688
+0.2%
330,250
+0.0%
0.38%
+6.4%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$21,047,250
+58.8%
1,425,000
+38.9%
0.38%
+68.8%
COGT SellCOGENT BIOSCIENCES INC$20,962,500
-48.5%
2,150,000
-37.5%
0.38%
-45.3%
IMGN  IMMUNOGEN INC$20,631,000
-15.9%
1,300,0000.0%0.37%
-10.6%
 AMYLYX PHARMACEUTICALS INC$20,449,285
-15.1%
1,116,8370.0%0.37%
-9.6%
WDAY SellWORKDAY INCcl a$20,071,287
-33.5%
93,420
-30.1%
0.36%
-29.2%
PCVX NewVAXCYTE INC$20,035,140393,000
+100.0%
0.36%
BILL NewBILL HOLDINGS INC$19,891,544183,214
+100.0%
0.36%
 ROIVANT SCIENCES LTD$19,742,704
+15.9%
1,690,3000.0%0.36%
+23.3%
RGEN  REPLIGEN CORP$18,922,190
+12.4%
119,0000.0%0.34%
+19.3%
BBIO SellBRIDGEBIO PHARMA INC$18,905,365
+16.8%
716,927
-23.8%
0.34%
+24.1%
BEPC BuyBROOKFIELD RENEWABLE CORPcl a sub vtg$18,581,079
-24.0%
776,152
+0.0%
0.33%
-19.1%
KROS  KEROS THERAPEUTICS INC$18,490,400
-20.7%
580,0000.0%0.33%
-15.7%
RCKT  ROCKET PHARMACEUTICALS INC$18,400,020
+3.1%
898,0000.0%0.33%
+9.6%
ROL NewROLLINS INC$18,303,944490,328
+100.0%
0.33%
NOVT BuyNOVANTA INC$18,077,456
-22.1%
126,028
+0.0%
0.32%
-17.1%
CMS BuyCMS ENERGY CORP$17,598,423
-6.8%
331,358
+3.1%
0.32%
-0.9%
NEP SellNEXTERA ENERGY PARTNERS LP$17,474,262
-78.4%
588,359
-57.3%
0.31%
-77.0%
VCYT  VERACYTE INC$16,345,560
-12.3%
732,0000.0%0.29%
-6.7%
CYTK  CYTOKINETICS INC$16,379,760
-9.7%
556,0000.0%0.29%
-4.2%
HLI NewHOULIHAN LOKEY INCcl a$16,028,580149,632
+100.0%
0.29%
INSM SellINSMED INC$16,038,421
-16.7%
635,185
-30.4%
0.29%
-11.4%
RPHM BuyRENEO PHARMACEUTICALS INC$15,825,051
+37.8%
2,078,142
+18.8%
0.28%
+46.4%
MSCI SellMSCI INC$15,198,969
+6.5%
29,623
-2.6%
0.27%
+13.3%
NBIX  NEUROCRINE BIOSCIENCES INC$15,187,500
+19.3%
135,0000.0%0.27%
+27.0%
SRPT  SAREPTA THERAPEUTICS INC$14,866,784
+5.9%
122,6430.0%0.27%
+12.7%
BMRN  BIOMARIN PHARMACEUTICAL INC$14,537,176
+2.1%
164,2990.0%0.26%
+8.3%
XENE  XENON PHARMACEUTICALS INC$14,139,029
-11.3%
413,9060.0%0.25%
-5.6%
BCRX  BIOCRYST PHARMACEUTICALS INC$13,947,600
+0.6%
1,970,0000.0%0.25%
+7.3%
VRNA NewVERONA PHARMA PLCsponsored ads$13,855,000850,000
+100.0%
0.25%
ESI BuyELEMENT SOLUTIONS INC$13,408,926
+16.7%
683,780
+14.2%
0.24%
+24.2%
BRKR SellBRUKER CORP$13,105,740
-19.7%
210,365
-4.7%
0.24%
-14.5%
INZY NewINOZYME PHARMA INC$13,125,0003,125,000
+100.0%
0.24%
BuyGXO LOGISTICS INCORPORATED$12,913,264
-6.6%
220,175
+0.0%
0.23%
-0.9%
EQT NewEQT CORP$12,831,396316,200
+100.0%
0.23%
DNLI BuyDENALI THERAPEUTICS INC$12,828,766
+38.7%
621,850
+98.4%
0.23%
+48.1%
RARE  ULTRAGENYX PHARMACEUTICAL IN$12,798,350
-22.7%
359,0000.0%0.23%
-17.9%
IEX SellIDEX CORP$12,125,902
-7.9%
58,292
-4.7%
0.22%
-1.8%
NTLA SellINTELLIA THERAPEUTICS INC$11,783,667
-41.4%
372,665
-24.4%
0.21%
-37.6%
EHC SellENCOMPASS HEALTH CORP$11,424,453
-11.2%
170,108
-10.5%
0.20%
-5.5%
EGP BuyEASTGROUP PPTYS INC$11,066,585
+91.7%
66,454
+99.8%
0.20%
+103.1%
 R1 RCM INC$11,087,074
-18.3%
735,7050.0%0.20%
-13.1%
ARDX NewARDELYX INC$10,995,6002,695,000
+100.0%
0.20%
CERE  CEREVEL THERAPEUTICS HLDNG I$10,696,700
-31.3%
490,0000.0%0.19%
-27.0%
RVMD BuyREVOLUTION MEDICINES INC$9,992,480
+3.6%
361,000
+0.1%
0.18%
+10.4%
FREQ NewFREQUENCY THERAPEUTICS INC$9,999,9993,597,122
+100.0%
0.18%
MASS  908 DEVICES INC$9,530,427
-2.9%
1,430,9950.0%0.17%
+3.0%
IDYA NewIDEAYA BIOSCIENCES INC$9,038,300335,000
+100.0%
0.16%
VRSK SellVERISK ANALYTICS INC$8,949,007
-35.2%
37,881
-38.0%
0.16%
-30.9%
PLD SellPROLOGIS INC.$8,915,646
-62.2%
79,455
-58.7%
0.16%
-59.9%
SYY SellSYSCO CORP$8,914,042
-37.2%
134,959
-29.5%
0.16%
-33.3%
VKTX  VIKING THERAPEUTICS INC$8,302,500
-31.7%
750,0000.0%0.15%
-27.3%
INBX NewINHIBRX INC$7,964,377434,026
+100.0%
0.14%
EQIX BuyEQUINIX INC$7,702,714
+3.2%
10,606
+11.4%
0.14%
+9.5%
ANAB NewANAPTYSBIO INC$7,668,920427,000
+100.0%
0.14%
ELS SellEQUITY LIFESTYLE PPTYS INC$6,973,378
-57.7%
109,455
-55.6%
0.12%
-55.2%
BEAM SellBEAM THERAPEUTICS INC$6,285,708
-57.1%
261,360
-43.1%
0.11%
-54.4%
PTGX  PROTAGONIST THERAPEUTICS INC$5,337,600
-39.6%
320,0000.0%0.10%
-35.6%
GPI NewGROUP 1 AUTOMOTIVE INC$4,630,14217,231
+100.0%
0.08%
RCUS  ARCUS BIOSCIENCES INC$4,308,000
-11.6%
240,0000.0%0.08%
-6.1%
VST NewVISTRA CORP$3,753,919113,138
+100.0%
0.07%
INTA NewINTAPP INC$2,882,15085,983
+100.0%
0.05%
NewTURNSTONE BIOLOGICS CORP$2,790,769708,317
+100.0%
0.05%
BuyARTERIS INC$2,597,640
-4.5%
399,023
+0.1%
0.05%
+2.2%
MDB NewMONGODB INCcl a$2,521,6657,291
+100.0%
0.04%
PXD NewPIONEER NAT RES CO$1,592,6186,938
+100.0%
0.03%
 XOMETRY INCnote 1.000% 2/0$1,530,948
-3.6%
2,100,0000.0%0.03%
+3.7%
NOW BuySERVICENOW INC$811,051
+59.3%
1,451
+60.2%
0.02%
+66.7%
ALV NewAUTOLIV INC$815,2568,450
+100.0%
0.02%
SPGI NewS&P GLOBAL INC$831,3082,275
+100.0%
0.02%
SHOP NewSHOPIFY INCcl a$729,60113,370
+100.0%
0.01%
EW BuyEDWARDS LIFESCIENCES CORP$678,528
+40.8%
9,794
+91.7%
0.01%
+50.0%
NewLINDE PLC$684,7521,839
+100.0%
0.01%
ALGN BuyALIGN TECHNOLOGY INC$587,741
+41.1%
1,925
+63.4%
0.01%
+57.1%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$595,178
+62.0%
6,849
+88.2%
0.01%
+83.3%
NVDA SellNVIDIA CORPORATION$498,499
-4.1%
1,146
-6.8%
0.01%0.0%
WM NewWASTE MGMT INC DEL$483,6923,173
+100.0%
0.01%
ZTS NewZOETIS INCcl a$389,0192,236
+100.0%
0.01%
COMP SellCOMPASS INCcl a$323,678
-28.2%
111,613
-13.4%
0.01%
-25.0%
NEE ExitNEXTERA ENERGY INC$0-3,163
-100.0%
-0.00%
ExitNERDWALLET INC$0-150,000
-100.0%
-0.02%
IONS ExitIONIS PHARMACEUTICALS INC$0-110,000
-100.0%
-0.08%
NDAQ ExitNASDAQ INC$0-182,708
-100.0%
-0.15%
ETNB Exit89BIO INC$0-642,073
-100.0%
-0.21%
ALKS ExitALKERMES PLC$0-562,233
-100.0%
-0.30%
ExitHASHICORP INC$0-749,122
-100.0%
-0.33%
CWEN ExitCLEARWAY ENERGY INCcl c$0-771,386
-100.0%
-0.37%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-397,141
-100.0%
-0.61%
KDNY ExitCHINOOK THERAPEUTICS INC$0-1,927,000
-100.0%
-1.25%
DOCS ExitDOXIMITY INCcl a$0-3,893,633
-100.0%
-2.24%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings